This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: HDL

News from ESC 2018: Not all HDL cholesterol is cardioprotective

October 2018 Br J Cardiol 2018;25:135–7 Online First

News from ESC 2018: Not all HDL cholesterol is cardioprotective

BJC Staff

Abstract

European Society of Cardiology congress 2018, held in Munich This study, conducted as part of the Emory Cardiovascular Biobank, investigated the relationship between HDL cholesterol levels and the risk of heart attack and death in 5,965 individuals, most of whom had heart disease. The average age of participants was 63 years and 35% were female. Participants were divided into five groups according to their HDL cholesterol level: less than 30 mg/dl (0.78 mmol/L), 31–40 mg/dl (0.8–1 mmol/L); 41–50 mg/dl (1.1–1.3 mmol/L); 51–60 mg/dl (1.3–1.5 mmol/L); and greater than 60 mg/dl (1.5 mmol/L). During a median follow-up of four years, 76

| Full text
Targeting residual risk: a new approach to treating CVD?

July 2014 Br J Cardiol 2014;21:108–12 doi:10.5837/bjc.2014.023

Targeting residual risk: a new approach to treating CVD?

Alan Begg, Iain Findlay

Abstract

Introduction Atherosclerosis is a systemic disease of the large- and medium-sized muscular arteries, which is characterised by endothelial dysfunction, vascular inflammation, and the build up of lipids, cholesterol, calcium, and cellular debris within the intima of the vessel wall. This build up results in plaque formation, vascular remodelling, acute and chronic luminal obstruction, abnormalities of blood flow and diminished oxygen supply to target organs.1 Plaque rupture and thrombosis result in the acute clinical complications of atherosclerosis. The process of atherosclerosis begins early in life and progresses over many decades. Rupture

| Full text
News from the American Heart Association Scientific Sessions 2010

February 2011 Br J Cardiol 2011;18:11-3

News from the American Heart Association Scientific Sessions 2010

Abstract

Highlights of the American Heart Association 2010 meeting held in November 2010, in Chicago, USA, included a breakthrough for the treatment of resistant hypertension, and another oral anticoagulant that could be used instead of warfarin in atrial fibrillation patients, without the need for monitoring. RAFT: CRT reduces deaths and hospitalisations in mild heart failure Adding cardiac-resynchronisation therapy (CRT) to implantable cardioverter defibrillator (ICD) and medication, led to a reduction in deaths and heart failure hospitalistions among patients with mild-to-moderate symptoms of heart failure in the RAFT (Resynchronisation-Defibrilla

| Full text
In brief

February 2011 Br J Cardiol 2011;18:15-6

In brief

BJ Cardio Staff

Abstract

NHA joins with BHS The Nurses Hypertension Association (NHA) has become part of the British Hypertension Society (BHS) after the BHS decided to invite nurses working in the field of hypertension and cardiovascular disease to be full members of the society. “This acknowledges the shift of care towards specialist nurses, particularly in primary care,” said Naomi Stetson, former head of the NHA. “In the current economic climate, it also made good business sense to have one united organisation.” All members of the NHA are now full BHS members and so the NHA has disbanded. “There is a strong Nurses Working Party within the society, which

| Full text

August 2002 Br J Cardiol 2002;9:

The cholesterol management debates

BJCardio editorial team

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now